A detailed history of Insight Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Insight Advisors, LLC holds 2,491 shares of ABBV stock, worth $444,369. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,491
Previous 2,475 0.65%
Holding current value
$444,369
Previous $424,000 15.8%
% of portfolio
0.13%
Previous 0.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$163.84 - $199.33 $2,621 - $3,189
16 Added 0.65%
2,491 $491,000
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $22,908 - $26,752
148 Added 6.36%
2,475 $424,000
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $1,118 - $1,274
7 Added 0.3%
2,327 $423,000
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $30,547 - $34,403
-222 Reduced 8.73%
2,320 $359,000
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $7,080 - $8,196
53 Added 2.13%
2,542 $378,000
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $52,208 - $64,970
394 Added 18.81%
2,489 $335,000
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $108,746 - $125,238
-752 Reduced 26.41%
2,095 $333,000
Q4 2022

Feb 21, 2023

SELL
$138.31 - $165.87 $228,764 - $274,348
-1,654 Reduced 36.75%
2,847 $460,000
Q3 2022

Dec 12, 2022

SELL
$134.21 - $153.93 $1,073 - $1,231
-8 Reduced 0.18%
4,501 $604,000
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $235,054 - $298,831
-1,708 Reduced 27.47%
4,509 $634,000
Q1 2022

Jun 02, 2022

BUY
$131.98 - $163.75 $65,990 - $81,875
500 Added 8.75%
6,217 $1.01 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $247,198 - $306,703
1,873 Added 48.73%
5,717 $927,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $194,770 - $246,441
1,813 Added 89.27%
3,844 $520,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1,170 - $1,328
-11 Reduced 0.54%
2,031 $238,000
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $54,919 - $61,183
-522 Reduced 20.36%
2,042 $236,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $38,362 - $42,232
375 Added 17.13%
2,564 $287,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $176,192 - $237,878
2,189 New
2,189 $235,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Insight Advisors, LLC Portfolio

Follow Insight Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Advisors, LLC with notifications on news.